These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 34175350)
1. Pseudoginsenoside-F11 ameliorates thromboembolic stroke injury in rats by reducing thromboinflammation. Gao Y; Liu Y; Yang X; Zhang T; Hou Y; Wang P; Liu Y; Yuan L; Zhang H; Wu C; Yang J Neurochem Int; 2021 Oct; 149():105108. PubMed ID: 34175350 [TBL] [Abstract][Full Text] [Related]
2. Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects. Liu YY; Zhang TY; Xue X; Liu DM; Zhang HT; Yuan LL; Liu YL; Yang HL; Sun SB; Zhang C; Xu HS; Wu CF; Yang JY CNS Neurosci Ther; 2017 Jul; 23(7):567-579. PubMed ID: 28485547 [TBL] [Abstract][Full Text] [Related]
3. Pseudoginsenoside-F11 Protects against Transient Cerebral Ischemia Injury in Rats Involving Repressing Calcium Overload. Zhang T; Wu C; Yang X; Liu Y; Yang H; Yuan L; Liu Y; Sun S; Yang J Neuroscience; 2019 Jul; 411():86-104. PubMed ID: 31129202 [TBL] [Abstract][Full Text] [Related]
4. Pseudoginsenoside-F11 promotes functional recovery after transient cerebral ischemia by regulating the microglia/macrophage polarization in rats. Hou Y; Yang D; Wang X; Wang H; Zhang H; Wang P; Liu Y; Gao X; Yang J; Wu C Int Immunopharmacol; 2021 Oct; 99():107896. PubMed ID: 34246061 [TBL] [Abstract][Full Text] [Related]
5. Pseudoginsenoside F11 ameliorates the dysfunction of the autophagy-lysosomal pathway by activating calcineurin-mediated TFEB nuclear translocation in neuron during permanent cerebral ischemia. Fu X; Liu Y; Zhang H; Yu X; Wang X; Wu C; Yang J Exp Neurol; 2021 Apr; 338():113598. PubMed ID: 33422553 [TBL] [Abstract][Full Text] [Related]
6. Pseudoginsenoside-F11 improves long-term neurological function and promotes neurogenesis after transient cerebral ischemia in mice. Yuan L; Sun S; Pan X; Zheng L; Li Y; Yang J; Wu C Neurochem Int; 2020 Feb; 133():104586. PubMed ID: 31756514 [TBL] [Abstract][Full Text] [Related]
7. Pseudoginsenoside-F11 Accelerates Microglial Phagocytosis of Myelin Debris and Attenuates Cerebral Ischemic Injury Through Complement Receptor 3. Liu Y; Wu C; Hou Z; Fu X; Yuan L; Sun S; Zhang H; Yang D; Yao X; Yang J Neuroscience; 2020 Feb; 426():33-49. PubMed ID: 31790669 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of pseudoginsenoside-F11 on permanent cerebral ischemia in rats by regulating calpain activity and NR2A submit-mediated AKT-CREB signaling pathways. Liu Y; Fu X; Liu Y; Zhang T; Cui P; Wang S; Liu L; Hou Z; Wang H; Zhao Y; Zhang Z; Zhang H; Wu C; Yang J Phytomedicine; 2022 Feb; 96():153847. PubMed ID: 34836744 [TBL] [Abstract][Full Text] [Related]
9. Pseudoginsenoside-F11 ameliorates ischemic neuron injury by regulating the polarization of neutrophils and macrophages in vitro. Hou Y; Yang D; Zhang Q; Wang X; Yang J; Wu C Int Immunopharmacol; 2020 Aug; 85():106564. PubMed ID: 32447220 [TBL] [Abstract][Full Text] [Related]
10. Pseudoginsenoside-F11 Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Neutrophil Infiltration and Accelerating Neutrophil Clearance. Wang P; Hou Y; Zhang W; Zhang H; Che X; Gao Y; Liu Y; Yang D; Wang J; Xiang R; Zhao M; Yang J Inflammation; 2019 Oct; 42(5):1857-1868. PubMed ID: 31332661 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation. Jin R; Xiao AY; Chen R; Granger DN; Li G Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092 [TBL] [Abstract][Full Text] [Related]
12. Pseudoginsenoside-F11 alleviates oligomeric β-amyloid-induced endosome-lysosome defects in microglia. Yao XC; Xue X; Zhang HT; Zhu MM; Yang XW; Wu CF; Yang JY Traffic; 2019 Jan; 20(1):61-70. PubMed ID: 30375163 [TBL] [Abstract][Full Text] [Related]
13. Pseudoginsenoside-F11 reduces cognitive impairment and white matter injury in vascular dementia by alleviating autophagy-lysosomal pathway deficiency. Wang H; Liu Y; Cui M; Guo Z; Zhao Y; Yang J; Wu C Phytomedicine; 2024 Oct; 133():155883. PubMed ID: 39059268 [TBL] [Abstract][Full Text] [Related]
14. Pseudoginsenoside-F11 attenuates cognitive impairment by ameliorating oxidative stress and neuroinflammation in d‑galactose-treated mice. Zhang Z; Yang H; Yang J; Xie J; Xu J; Liu C; Wu C Int Immunopharmacol; 2019 Feb; 67():78-86. PubMed ID: 30537634 [TBL] [Abstract][Full Text] [Related]
15. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens. Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348 [TBL] [Abstract][Full Text] [Related]
16. Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB, MAPKs and Akt signaling pathways. Wang X; Wang C; Wang J; Zhao S; Zhang K; Wang J; Zhang W; Wu C; Yang J Neuropharmacology; 2014 Apr; 79():642-56. PubMed ID: 24467851 [TBL] [Abstract][Full Text] [Related]
17. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice. Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318 [TBL] [Abstract][Full Text] [Related]
18. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model. Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023 [TBL] [Abstract][Full Text] [Related]
19. Pseudoginsenoside-F11 ameliorates okadiac acid-induced learning and memory impairment in rats via modulating protein phosphatase 2A. Chu J; Wang J; Cui L; Liu S; An N; Han J; Che X; Wu C; Yang J Mech Ageing Dev; 2021 Jul; 197():111496. PubMed ID: 33957218 [TBL] [Abstract][Full Text] [Related]
20. Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke. Ishrat T; Fouda AY; Pillai B; Eldahshan W; Ahmed H; Waller JL; Ergul A; Fagan SC J Cereb Blood Flow Metab; 2019 Aug; 39(8):1635-1647. PubMed ID: 29537907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]